Lv11
30 积分 2023-11-21 加入
Psoriasis
5小时前
待确认
Real-World Safety of Apremilast: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System (FAERS)
10天前
已完结
Tonsillar Microbiota Alterations Contribute to Immune Responses in Psoriasis by Skewing Aged Neutrophils
17天前
已完结
Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics
30天前
已完结
Extension of Secukinumab and Ixekizumab Dose for Moderate‐To‐Severe Psoriasis in Low Disease Activity Intervals
1个月前
已完结
Apremilast for Recalcitrant Cutaneous Dermatomyositis: A Review of Current Literature
1个月前
已完结
Traumatic Panniculitis
3个月前
已完结
Persistence of apremilast in moderate‐to‐severe psoriasis: a real‐world analysis of 14 147 apremilast‐ and methotrexate‐naive patients in the French National Health Insurance database
5个月前
已完结
Early inadequate response to biological agents portends treatment failure at 6 months in patients with psoriasis: a multicenter, prospective cohort study
5个月前
已完结
Safety evaluation of apremilast for the treatment of psoriasis
7个月前
已完结
皖公网安备34019202002308
